Graphene synthesis1

Home

Zentek: Manages a portfolio of businesses in air quality, infection control, critical minerals and biosciences.

Zentek is an ISO 13485‑certified intellectual property development and commercialization company that builds and advances distinct brands.

How Zentek Creates Value

Zentek acts as a platform that allocates capital and expertise across its brands to create long‑term value for shareholders.

  • Disciplined capital allocation across three differentiated but complementary businesses: ZenGUARD , Triera Biosciences and Albany Graphite.
  • Central IP, regulatory and commercialization capabilities that each brand can leverage to move from lab to market more efficiently.
  • Multiple paths to value realization, including product revenue, government contracts and grants, strategic partnerships, spin‑outs and potential royalty structures.

Who is Zentek?

Zentek is an ISO 13485‑certified intellectual property technology company focused on the research, development and commercialization of innovative products that give commercial partners a competitive edge by making their products better, safer and greener. The company uses its expertise in graphene‑based nanomaterials and aptamer technologies, together with strategic partnerships, to build and scale distinct brands in filtration, biosciences and critical minerals.

Partner or Invest with Zentek

Whether you are exploring advanced filtration solutions and personal protective equipment, aptamer‑based therapeutics or high‑purity graphite supply, Zentek is actively seeking strategic partners and long‑term investors who share our vision of applying capital to help solve real‑world challenges.
Contact Business Development